Medical Robotics Market is Projected to Reach $86.40 Billion by 2035
Medical robotics market is witnessing substantial growth owing to the increasing adoption of robot-assisted surgical procedures, rising demand for minimally invasive surgeries, and continuous advancements in robotic technologies across healthcare facilities. Growing utilization of surgical robotic systems, rehabilitative robotic systems, noninvasive radiosurgery robots, and hospital pharmacy robotic systems is significantly improving precision, efficiency, and patient outcomes. In addition, the rising prevalence of chronic diseases, increasing healthcare automation, and growing investments in advanced medical infrastructure are further supporting market expansion. Technological innovations integrating artificial intelligence, machine learning, and real-time imaging capabilities are also expected to accelerate market growth during the forecast period.
Browse the full report description of “Medical Robotics Market Size, Share & Trends Analysis Report by Product (Surgical Robotic Systems, Rehabilitative Robotic Systems, Noninvasive Radiosurgery Robots, Hospital & Pharmacy Robotic Systems, and Others) and Forecast Period (2026-2035)” at https://www.omrglobal.com/industry-reports/medical-robotics-market
January 2026 – Microbot Medical advanced commercialization of LIBERTY® robotic system
In January 2026, Microbot Medical announced continued commercialization milestones for its LIBERTY® Endovascular Robotic System following FDA 510(k) clearance received in 2025. Key developments included limited market release deployment, first hospital adoption at Emory University Hospital, positive ACCESS-PVI clinical trial results, and a planned full commercial launch in Q2 2026. The robotic platform is designed for minimally invasive peripheral vascular procedures while significantly reducing physician radiation exposure during interventions. The development reflects increasing demand for robotic-assisted endovascular technologies focused on procedural precision, physician safety, and improved clinical efficiency.
July 2025 – Zimmer Biomet acquired Monogram Technologies to expand autonomous surgical robotics
In July 2025, Zimmer Biomet announced a definitive agreement to acquire Monogram Technologies for approximately $177 million. The acquisition strengthens Zimmer Biomet’s orthopedic robotics portfolio through the addition of AI-guided robotic surgery systems, semi-autonomous knee replacement robotics, and fully autonomous surgical robotics development capabilities. Monogram’s CT-based robotic knee arthroplasty technology received FDA 510(k) clearance in March 2025 and is expected to launch commercially in 2027. The acquisition also supports the growing adoption of robotic-assisted orthopedic procedures aimed at improving surgical precision, workflow efficiency, and patient outcomes.
December 2025 – Medtronic received FDA clearance for Hugo robotic surgery system
In December 2025, Medtronic received FDA clearance for its Hugo soft-tissue robotic surgery platform for its first U.S. indication. The approval positioned Medtronic as a major competitor to Intuitive Surgical in the robotic-assisted minimally invasive surgery market. The Hugo robotic platform is designed to support enhanced surgical precision, improved visualization, and greater flexibility across multiple soft-tissue procedures. The clearance also reflects the growing expansion of robotic-assisted surgical technologies within hospitals and healthcare systems globally.
About OMR Global
OMR Global is a market intelligence and strategic consulting firm specializing in growth advisory, competitive intelligence, and AI-enabled business research across global B2B industries.
The company supports enterprises, investors, and technology providers with actionable insights for market entry, investment analysis, procurement strategy, commercialization, and business expansion. OMR Global combines industry expertise, primary research, analytics, and digital intelligence tools to help organizations navigate evolving market landscapes and identify growth opportunities.
OMR Digital Offerings
- Pulse Intelligence Platform – AI-powered market intelligence suite designed to deliver analyst-grade insights faster and more efficiently. Built on 12+ years of research expertise and enhanced with AI-driven analytics, Pulse helps organizations transform large volumes of market and company data into actionable intelligence within hours instead of weeks. Trusted by Fortune 500 enterprises, global investment banks, strategy consultancies, and PE & VC firms, Pulse supports strategic decision-making across investment evaluation, competitive benchmarking, AI readiness, and market positioning.
Other Offerings
- Lead Generation – Verified B2B prospect data, ICP targeting, and intent-based sales intelligence
- RFx Support – End-to-end RFP, RFI, and RFQ support with vendor benchmarking and evaluation frameworks
OMR Global delivers data-driven intelligence solutions designed to support strategic decision-making, operational efficiency, and long-term business growth.
To find out more, visit www.omrglobal.com
Contact:
Mr. Anurag Tiwari
305-308, Commerce House, Janjeerwala Square,
Indore, Madhya Pradesh 452001
India
+91-780-304-0404